These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3289796)

  • 1. Clinical biochemistry of peroxisomal disorders.
    Kaiser E; Kramar R
    Clin Chim Acta; 1988 Mar; 173(1):57-80. PubMed ID: 3289796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic diseases caused by peroxisomal dysfunction. New findings in clinical and biochemical studies.
    Schutgens RB; Wanders RJ; Nijenhuis A; van den Hoek CM; Heymans HS; Schrakamp G; Bleeker-Wagemakers EM; Delleman JW; Schram AW; Tager JM
    Enzyme; 1987; 38(1-4):161-76. PubMed ID: 3440444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peroxisomal hereditary diseases].
    Chandoga J; Tomková M; Hlavatá A
    Bratisl Lek Listy; 1997 Jan; 98(1):32-42. PubMed ID: 9264803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
    Poulos A; Singh H; Paton B; Sharp P; Derwas N
    Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches in peroxisomal disorders.
    Moser HW
    Dev Neurosci; 1987; 9(1):1-18. PubMed ID: 3297624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
    Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
    Molzer B; Stöckler S; Bernheimer H
    Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.
    Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I
    Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of the cerebrohepatorenal syndrome of Zellweger and other peroxisomal disorders.
    Zellweger H; Maertens P; Superneau D; Wertelecki W
    South Med J; 1988 Mar; 81(3):357-64. PubMed ID: 2450404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisomal functions in classical Refsum's disease: comparison with the infantile form of Refsum's disease.
    Wanders RJ; Heymans HS; Schutgens RB; Poll-Thé BT; Saudubray JM; Tager JM; Schrakamp G; van den Bosch H
    J Neurol Sci; 1988 Apr; 84(2-3):147-55. PubMed ID: 2454298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisomal disorders in neurology.
    Wanders RJ; Heymans HS; Schutgens RB; Barth PG; van den Bosch H; Tager JM
    J Neurol Sci; 1988 Dec; 88(1-3):1-39. PubMed ID: 3066850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Zellweger syndrome, neonatal adrenoleukodystrophy or infantile Refsum's disease in a case with generalized peroxisome defect?].
    Schmitt K; Molzer B; Stöckler S; Tulzer G; Tulzer W
    Wien Klin Wochenschr; 1993; 105(11):320-2. PubMed ID: 7687405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disorders related to the metabolism of phytanic acid.
    Stokke O; Skjeldal OH; Høie K
    Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyceryl ethers in peroxisomal disease.
    Poulos A; Bankier A; Beckman K; Johnson D; Robertson EF; Sharp P; Sheffield L; Singh H; Usher S; Wise G
    Clin Genet; 1991 Jan; 39(1):13-25. PubMed ID: 1705185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver pathologies due to peroxisome disorders].
    Lovisetto P; Raviolo P
    Recenti Prog Med; 1994 Feb; 85(2):134-41. PubMed ID: 8184191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polarizing inclusions in some organs of children with congenital peroxisomal diseases (Zellweger's, Refsum's, chondrodysplasia punctata (rhizomelic form), X-linked adrenoleukodystrophy).
    Kerckaert I; Dingemans KP; Heymans HS; Vamecq J; Roels F
    J Inherit Metab Dis; 1988; 11(4):372-86. PubMed ID: 2468818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peroxisomal diseases--a survey].
    Theron JJ; van Papendorp DH
    S Afr Med J; 1996 Jun; 86(6):685-90. PubMed ID: 8764428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of a novel arachidonic acid metabolite in peroxisomes.
    Gordon JA; Heller SK; Rhead WJ; Watkins PA; Spector AA
    Prostaglandins Leukot Essent Fatty Acids; 1995; 52(2-3):77-81. PubMed ID: 7540307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy.
    Small GM; Santos MJ; Imanaka T; Poulos A; Danks DM; Moser HW; Lazarow PB
    J Inherit Metab Dis; 1988; 11(4):358-71. PubMed ID: 2468817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.
    Skjeldal OH; Stokke O; Refsum S; Norseth J; Petit H
    J Neurol Sci; 1987 Jan; 77(1):87-96. PubMed ID: 2433405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.